Literature DB >> 34309860

Influence of sex hormones on the immune response to leishmaniasis.

Layana Pachêco de Araújo Albuquerque1, Amanda Miranda da Silva2,3, Francisca Miriane de Araújo Batista4, Ingridi de Souza Sene3, Dorcas Lamounier Costa5, Carlos Henrique Nery Costa6.   

Abstract

The differences in morbidity and mortality patterns and life expectancy between the sexes are well established in different infectious and parasitic conditions, such as in leishmaniases, in which biological, genetic, sexual and hormonal variations can modulate the immune response indicating greater infectivity, prevalence and clinical severity in men. In this regard, in seeking the understanding of factors related to protection and susceptibility to infection, this review aimed to discuss the influence of sex hormones on the immune response to leishmaniases. In the literature, sex hormone variations promote differences in the innate, humoral and cell-mediated immune response, leading to greater susceptibility, mortality and complications in males. Epidemiological estimates confirm these results, showing a predominance of the disease, in its different clinical forms, in men and suggesting that sexual variations influence immunomodulatory mechanisms since the prevalence of cases comprises the post-puberty and adulthood period. In this perspective, the action of sex hormones has been investigated in different clinical models, highlighting the potential of testosterone in immunosuppression, given its association with greater susceptibility and poor control of parasite load and the induction of cell apoptosis and attenuation of pro-inflammatory signalling pathways. Therefore, hormonal variations influence the immune response among males and females against leishmaniases, in which androgens may present immunosuppressive potential, while steroids present immunomodulatory characteristics.
© 2021 John Wiley & Sons Ltd.

Entities:  

Keywords:  immune response; infectious diseases; leishmaniases; sex bias; sex hormones

Year:  2021        PMID: 34309860     DOI: 10.1111/pim.12874

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  2 in total

1.  Epidemiological and clinical factors associated with lethality from Human Visceral Leishmaniasis in Northeastern Brazil, 2007 to 2018.

Authors:  Kellyn Kessiene de Sousa Cavalcante; Clarice Pessoa Almeida; Reagan Nzundu Boigny; Francisco Roger Aguiar Cavalcante; Francisco Gustavo Silveira Correia; Caroline Mary Gurgel Dias Florêncio; Carlos Henrique Alencar
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2022-09-05       Impact factor: 2.169

2.  Meglumine antimoniate was associated with a higher cure rate than liposomal amphotericin B in the treatment of American tegumentary leishmaniasis: A retrospective cohort study from a Leishmania braziliensis-endemic area.

Authors:  Daniel Holanda Barroso; Renata Trindade Gonçalves; Joadyson Silva Barbosa; Jorgeth de Oliveira Carneiro da Motta; Gustavo Subtil Magalhães Freire; Ciro Martins Gomes; Raimunda Nonata Ribeiro Sampaio
Journal:  Front Cell Infect Microbiol       Date:  2022-09-23       Impact factor: 6.073

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.